Monday 16 Jun, 2025 09:02 PM
Site map | Locate Us | Login
   Nucleus Software appoints Aabhinna Khare as CMO to lead global brand transformation    Rategain Travel Technologies Ltd leads losers in 'A' group    Karma Energy Ltd leads losers in 'B' group    Zydus Life subsidiary ZHL appoints Swati Dalal as MD    GRM Overseas jumps 26% in eight days    Volumes jump at Anand Rathi Wealth Ltd counter    Algoquant Fintech incorporates WOS, Algoquant Global Securities    Desco Infratech slides after CFO Prinkle Sanjay Jain resigns    Punjab & Sind Bank drops for fifth straight session    Central Bank of India eases for fifth straight session    Indian Overseas Bank drops for fifth straight session    UCO Bank drops for fifth straight session    Bank of India down for fifth straight session    Tips Music Ltd down for fifth straight session    Tata Consumer Products Ltd drops for fifth straight session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Dishman Carbogen Amcis' Ahmedabad facility clears USFDA inspection without observations
16-Jun-25   12:15 Hrs IST

The inspection was conducted from 9 June to 13 June 2025. According to the company's statement, the audit concluded without any observations or the issuance of a Form 483, indicating that the USFDA found no procedural or compliance-related concerns during the inspection.

As a result, the company's facilities at Naroda and Bavla in India, along with multiple group facilities in Switzerland and the Netherlands, continue to maintain USFDA approval.

The official announcement was made on Saturday, 14 June 2025.

Dishman Carbogen Amcis is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. It provides a range of development and manufacturing solutions at locations in Europe, China and in India.

The company reported a consolidated net profit of Rs 43.09 crore in Q4 March 2025 as against a net loss of Rs 69.92 crore in Q4 March 2024. Revenue from operations rose 9.41% year-on-year to Rs 716.34 crore in Q4 March 2025.

The counter declined 2.29% to Rs 273.05 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 41993027
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited